E
Zentalis Pharmaceuticals, Inc. ZNTL
$1.77 -$0.04-2.21%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -40.16M -88.28M 10.07M -60.92M -55.53M
Total Depreciation and Amortization 321.00K 327.00K 324.00K 337.00K 348.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 3.05M 38.71M -46.06M 9.71M 11.74M
Change in Net Operating Assets -7.26M 14.10M -16.31M 10.27M 4.78M
Cash from Operations -44.05M -35.14M -51.97M -40.60M -38.67M
Capital Expenditure 0.00 -181.00K -40.00K -173.00K -91.00K
Sale of Property, Plant, and Equipment 0.00 65.00K -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 48.24M 34.61M 61.59M -41.89M -117.36M
Cash from Investing 48.24M 34.49M 61.55M -42.06M -117.45M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 92.00K 9.00K 248.00K 0.00 309.00K
Repurchase of Common Stock 0.00 0.00 -241.00K -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 92.00K 9.00K 7.00K 0.00 309.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 4.29M -640.00K 9.58M -82.66M -155.81M
Weiss Ratings